Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix

This study is currently recruiting participants.

Study NCT00946556 Information provided by University of Toronto

First Received: July 23, 2009 Last Updated: April 14, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	September 2011
Estimated Primary Completion Date:	April 2011 (Final data collection date for primary outcome measure)